Typically, a value chain in the biotechnology industry refers to a …show more content…
The whole consistent marketing approach creates trust and good relationships with the patients which can results in customer loyalty. This can give the company a competitive advantage if patents expire. Service: Genentech is committed to patients having access to their therapies. Since 1985, the company has donated approximately $1.5 billion in free medicine to uninsured patients. This can also support the already mentioned customer loyalty. It also opens a source for clinical studies and valuable feedback. 2. C1. R & D generation
C2. Time-to-market
C3. Customer relations
C4. Public / institutional relations
C5. Product portfolio / patents
C6. Marketing
R1. Manufacturing facilities
R2. Brand name / reputation
R3. Human resources
R4. Research infrastructure
Resources and Capabilities Matrix
R4
R3
R2
C4
C3
C2
C1
R1
C5
Relative Strength
Importance
C6
3. Strategic Implications
Given the internal analysis of the company, one can see that the key strengths of Genentech are its Human Resources Management, extensive, innovative Research and Development as well as a strong and diversified product portfolio and well-equipped manufacturing facilities, which are also vital for its success. Genentech should ensure to sustain these strengths by further collaborating with research institutes, leading universities and other companies in this field. Moreover attempts in the Human Resources field to attract employees from